Background: Recent meta-analyses of the efficacy of probiotics for preventing diarrhea
associated with Clostridium difficile have concluded there is a large effect favouring …

Objective Clostridium difficile‐associated diarrhea (CDAD) accounts for up to 25% of
patients with antibiotic‐associated diarrhea (AAD). We aimed to determine which probiotic is …

Introduction Clostridium difficile infection (CDI) is the leading cause of antibiotic-associated
diarrhea. CDI has increased in incidence and severity over the past decade, and is a …

Clostridium difficile infections are a global clinical concern and are one of the leading
causes of nosocomial outbreaks. Preventing these infections has benefited from …

Background: The recent increase in the number and severity of cases of nosocomial
Clostridium difficile-associated diarrhea (CDAD) has prompted interest in the use of …

Clostridium difficile infection (CDI) has become the leading healthcare-associated infection
and cause of outbreaks around the world. Although various innovative treatments have been …

BACKGROUND: The efficacy of probiotics for the prevention of Clostridium difficile infection
(CDI) is highly controversial, particularly with regard to the prevention of recurrent CDI. We …

Background: Antibiotic treatment may disturb the resistance of gastrointestinal flora to
colonization. This may result in complications, the most serious of which is Clostridium …

Clostridium difficile is a bacterium that affects the gastrointestinal tract and is the leading
cause of antibiotic-associated diarrhea. A wide range of probiotics has been studied and …

Background Clostridium difficile-associated diarrhea (CDAD) is a major public health
problem because of significant morbidity and mortality, and many clinicians pay attention to …